M Safi

M Safi, PhD, is currently engaged in CMC preclinical development at argenx since 2023, with an extensive background in analytical method development and research. M Safi serves as a council member at NineSigma and GLG since 2020. Prior experience includes roles as analytical project leader at The Janssen Pharmaceutical Companies of Johnson & Johnson, and UCB, along with research and development scientist at EXOTHERA, focusing on gene therapy and physico-chemical method development. Previous positions include scientist at UNIVERCELLS, analytical method development scientist at Dr. Reddy's Laboratories, and as a doctoral researcher at the University of Antwerp specializing in mass spectrometry. Educational achievements comprise a Doctor of Pharmacy from the University of Antwerp/University of Gent and a Master of Science in Analytical Chemistry from the University of Tabriz.